Cardiovascular risk in women with polycystic ovary syndrome.

L. W. Cho, Stephen Atkin

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that has received an immense amount of attention in the recent years due to the possible associated risk of cardiovascular disease. Women with PCOS demonstrate an adverse cardiovascular profile characteristic of the cardiometabolic syndrome and an established risk of progression to type 2 diabetes. Despite the presence of cardiovascular risk factors and increased surrogate markers of cardiovascular disease, it is unclear if they develop accelerated atherosclerosis. This article summarized the recent development and findings of cardiovascular risk in women with PCOS, and finally the therapeutic options will be discussed.

Original languageEnglish
Pages (from-to)263-273
Number of pages11
JournalMinerva Endocrinologica
Volume32
Issue number4
Publication statusPublished - Dec 2007
Externally publishedYes

Fingerprint

Polycystic Ovary Syndrome
Cardiovascular Diseases
Type 2 Diabetes Mellitus
Atherosclerosis
Biomarkers
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Cardiovascular risk in women with polycystic ovary syndrome. / Cho, L. W.; Atkin, Stephen.

In: Minerva Endocrinologica, Vol. 32, No. 4, 12.2007, p. 263-273.

Research output: Contribution to journalReview article

@article{92b225b10fa946138cfc01a9cb520609,
title = "Cardiovascular risk in women with polycystic ovary syndrome.",
abstract = "Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that has received an immense amount of attention in the recent years due to the possible associated risk of cardiovascular disease. Women with PCOS demonstrate an adverse cardiovascular profile characteristic of the cardiometabolic syndrome and an established risk of progression to type 2 diabetes. Despite the presence of cardiovascular risk factors and increased surrogate markers of cardiovascular disease, it is unclear if they develop accelerated atherosclerosis. This article summarized the recent development and findings of cardiovascular risk in women with PCOS, and finally the therapeutic options will be discussed.",
author = "Cho, {L. W.} and Stephen Atkin",
year = "2007",
month = "12",
language = "English",
volume = "32",
pages = "263--273",
journal = "Minerva Endocrinologica",
issn = "0391-1977",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "4",

}

TY - JOUR

T1 - Cardiovascular risk in women with polycystic ovary syndrome.

AU - Cho, L. W.

AU - Atkin, Stephen

PY - 2007/12

Y1 - 2007/12

N2 - Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that has received an immense amount of attention in the recent years due to the possible associated risk of cardiovascular disease. Women with PCOS demonstrate an adverse cardiovascular profile characteristic of the cardiometabolic syndrome and an established risk of progression to type 2 diabetes. Despite the presence of cardiovascular risk factors and increased surrogate markers of cardiovascular disease, it is unclear if they develop accelerated atherosclerosis. This article summarized the recent development and findings of cardiovascular risk in women with PCOS, and finally the therapeutic options will be discussed.

AB - Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women that has received an immense amount of attention in the recent years due to the possible associated risk of cardiovascular disease. Women with PCOS demonstrate an adverse cardiovascular profile characteristic of the cardiometabolic syndrome and an established risk of progression to type 2 diabetes. Despite the presence of cardiovascular risk factors and increased surrogate markers of cardiovascular disease, it is unclear if they develop accelerated atherosclerosis. This article summarized the recent development and findings of cardiovascular risk in women with PCOS, and finally the therapeutic options will be discussed.

UR - http://www.scopus.com/inward/record.url?scp=39749096632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=39749096632&partnerID=8YFLogxK

M3 - Review article

VL - 32

SP - 263

EP - 273

JO - Minerva Endocrinologica

JF - Minerva Endocrinologica

SN - 0391-1977

IS - 4

ER -